Ductal carcinoma in situ (DCIS) of the breast is a heterogenous disease with varying clinical outcomes. Current classification of DCIS is based on cytological and architectural features. Although some of these features correlates with the risk of local recurrence, they can be determined only with moderate consistency and none of them is able to accurately predict the development of invasive disease. Therefore the identification of novel molecular markers that correlate with the clinical behavior of DCIS is of utmost importance. The specific goals of this proposal are aimed at the identification and evaluation of such markers using the combination of comprehensive gene expression analysis and tissue microarrays. In order to define genes implicated in DCIS, we have analyzed the gene expression profiles of DCIS and normally mammary epithelium using SAGE (Serial Analysis of Gene Expression) and identified over 300 differentially expressed transcripts. To further analyze how reproducibly these genes are differentially expressed we propose to generate tissue microarrays from hundreds of samples of benign breast tissue and in situ and invasive breast carcinomas. These tissue microarrays will then be used to rapidly screen DCIS specific transcripts using in situ hybridization and immunohistochemistry. The clinical usefulness of genes with consistently different expression in DCIS will be evaluated using a tissue microarray generated from DCIS cases with known clinical outcome. Identification of clinically useful molecular markers that would predict the behavior of DCIS could lead to the individualized treatment of patients diagnosed with this disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA089393-03
Application #
6667437
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-30
Project End
2003-09-29
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Kabraji, Sheheryar; Ni, Jing; Lin, Nancy U et al. (2018) Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain? Clin Cancer Res 24:1795-1804
Punglia, Rinaa S; Jiang, Wei; Lipsitz, Stuart R et al. (2018) Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat 167:751-759
Liu, Hui; Murphy, Charles J; Karreth, Florian A et al. (2018) Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer. Cancer Discov 8:354-369
Asdourian, Maria S; Swaroop, Meyha N; Sayegh, Hoda E et al. (2017) Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery. J Clin Oncol 35:3934-3941
Sun, Fangdi; Skolny, Melissa N; Swaroop, Meyha N et al. (2016) The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema. Breast Cancer Res Treat 157:229-240
Ferguson, Chantal M; Swaroop, Meyha N; Horick, Nora et al. (2016) Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer. J Clin Oncol 34:691-8
Miller, Cynthia L; Colwell, Amy S; Horick, Nora et al. (2016) Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study. Ann Surg 263:399-405
Sherr, Charles J; Beach, David; Shapiro, Geoffrey I (2016) Targeting CDK4 and CDK6: From Discovery to Therapy. Cancer Discov 6:353-67
Asdourian, Maria S; Skolny, Melissa N; Brunelle, Cheryl et al. (2016) Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. Lancet Oncol 17:e392-405
Kochupurakkal, Bose S; Iglehart, J Dirk (2016) Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA. Genom Data 7:92-3

Showing the most recent 10 out of 291 publications